Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Google Tag Manager

HSTS

Google Analytics

Content Delivery Network

Amazon

Global Site Tag

DoubleClick.Net

Senior Vice President, Technical Operations

Chris Lorenz

VP, Corporate Controller

May Liu

Vice President, Global Customer Experience & Commercial Innovation

Megan Sullivan

Senior Vice President, Head of Gene Therapy Research and Technical Operations

Morten Sogaard

Associate Director, Manufacturing

Alex Young

Associate Director, Upstream Process Development

Andrew Fong

Associate Director - Gene Therapy Competitive Intelligence & Market Planning

Anita Rajamani

Operations

Ankita Shah

Anna Hassinger

Director, BioAnalytics

Bala Medicherla

California Health Care Companies (Top 10K)

West Coast Health Care Companies (Top 10K)

San Francisco Bay Area Companies With More Than 50 Employees (Top 10K)

Western US Biotechnology Companies

Astellas Gene Therapies is a biotechnology company that develops new gene therapy treatments and medicines.

San Francisco

California

United States

North America

Astellas Gene Therapies

In shutdown of gene therapy manufacturing facility, Astellas closes Bay Area biotech chapter

Astellas Gene Therapies on LinkedIn: #genetherapy

Astellas Gene Therapies’ Post

Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor

Carolyn Sasse on LinkedIn: I am proud to represent the amazing team who has directly contributed to…

An investigational gene therapy designed to deliver functional copies of the MTM1 gene into skeletal muscle cells for patients with X-Linked Myotubular Myopathy.

An investigational gene therapy designed to deliver functional copies of the human acid alpha-glucosidase gene (GAA) into muscles for patients with Pompe disease.

An investigational AAV gene therapy designed to restore functional FXN expression and increase frataxin protein levels for patients with Friedreich ataxia.

An investigational recombinant gene therapy designed to insert a functional copy of the MBNL1 gene for patients with Myotonic Dystrophy type 1.

A preclinical next-generation investigational gene therapy that delivers a functional copy of the MTM1 gene via a novel MyoAAV capsid for X-linked myotubular myopathy.

A process built around innovative science, an expanding adeno-associated virus (AAV) platform, and internal manufacturing capability focusing on rare diseases of the eye, CNS, and neuromuscular system.

India

Asia

Ukraine

Europe

HTML5

Lightbox

Wistia

Amazon EC2

Vimeo

jQuery

Apache Server

Wordpress

Google Fonts

Astellas Gene Therapies is a center of excellence dedicated to developing genetic medicines with the potential to deliver transformative value for patients. Their focus is on rare diseases of the eye, CNS, and neuromuscular system, with a commitment to discovering, developing, and delivering a broad portfolio of transformative therapies for patients with genetic diseases around the world.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 11:15 PM	f4398fd3
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 11:15 PM	cfbccf3e
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	3c6d2fc3
crunchbase profile	general	Nov 25, 2024 11:39 AM	98640de4
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:16 PM	ef71f4a9
peers	general
news basic	general	Mar 8, 2024 11:15 PM	6c6f677d
bundesanzeiger	filings
financials download nd	financials
private financials	financials

ASTE

COM:ASTELLASGENETHERAPIES

Astellas Gene Therapies